	销售		日
Acadia Pharmaceuticals	USD 268.06M	15.94M	2026-03
Adma Biologics	USD 114.5M	24.66M	2026-03
ALKERMES	USD 392.91M	8.41M	2026-03
Alterity Therapeutics Limited	AUD 596.04K	584.66K	2025-12
AstraZeneca	USD 15.29B	213M	2026-03
BioCryst Pharmaceuticals	USD 406.56M	247.16M	2025-12
Bristol-Myers Squibb	USD 11.49B	1.01B	2026-03
Cipla	INR 65.41B	9.77B	2026-03
Clal Biotechnology	ILS 3.41M	2M	2022-12
Compugen	USD 6.35M	60.98M	2026-03
CSL	USD 8.33B	4.79B	2025-12
Eli Lilly	USD 19.8B	500M	2026-03
Esperion Therapeutics	USD 168.45M	81.14M	2025-12
GlaxoSmithKline	GBP 7.63B	991M	2026-03
Grifols	EUR 2B	306.7M	2026-03
Halozyme Therapeutics	USD 377M	74.76M	2026-03
Ionis Pharmaceuticals	USD 246M	43M	2026-03
J&J	USD 24.1B	500M	2026-03
Merck	USD 16.29B	110M	2026-03
Minerva Neurosciences	USD 0	0	2024-09
Neurocrine Biosciences	USD 811M	5.5M	2026-03
Novartis	USD 13.11B	226M	2026-03
Novavax	USD 147.14M	76.69M	2025-12
Pfizer	USD 14.5B	3.08B	2026-03
Roche Holding	CHF 15.65B	274.5M	2025-12
Sanofi	EUR 11.24B	60M	2026-03
Takeda	JPY 1.09T	100B	2026-03
Vanda Pharmaceuticals	USD 198.77M	151.12M	2024-12